U.S. Personal Products Stock News

If you are wondering whether Clorox is fairly priced or offering value right now, it helps to start by looking at how the share price and the underlying business line up. The stock last closed at US$121.45, with returns of 5.6% over 7 days, 14.4% over 30 days and 20.4% year to date, while the 1 year, 3 year and 5 year returns sit at 14.8%, 11.6% and 22.0% declines respectively. Recent news around Clorox has focused on the company as a long established household products name and on how...

Why BrightView’s latest update matters for shareholders BrightView Holdings (BV) recently reported quarterly results showing a larger net loss, reaffirmed its 2026 revenue outlook of US$2.670b to US$2.730b, and completed a share buyback that retired 2.32% of its stock. See our latest analysis for BrightView Holdings. BrightView’s 1-day share price return of 3.35% and 90-day share price return of 11.83% suggest momentum has been firming around the reaffirmed 2026 revenue outlook, even though...

Fresh analyst attention meets expanding business footprint BofA Securities has just initiated coverage on Remitly Global (RELY) with a buy rating. Investors are also weighing the recent expansion of Remitly Business into the U.K. and Canada and a sharp sequential jump in send volumes. See our latest analysis for Remitly Global. The recent expansion of Remitly Business and fresh analyst coverage arrive as momentum has been mixed, with a 10.2% 7 day share price return and 11.7% 90 day share...

Horace Mann Educators (HMN) is back in focus after reporting full year 2025 earnings, with revenue of US$1,701.4 million and net income of US$162.1 million, alongside commentary on stronger profitability. See our latest analysis for Horace Mann Educators. At a share price of US$42.95, Horace Mann Educators has seen weaker short term momentum, with a 7 day share price return of 4.39% and a 30 day share price return of 3.44%. Its 1 year total shareholder return of 4.48% and 5 year total...

Packaging Corporation of America, NYSE:PKG, is facing fresh scrutiny over declining operating margin and return on invested capital. Recent multi year pressure on these profitability metrics is raising questions about rising costs and the strength of the core business. The discussion comes as the stock trades around $241.78, drawing attention from investors tracking both price performance and fundamentals. For investors watching NYSE:PKG, the concern is less about short term price moves and...

In early February 2026, Ball Corporation reported fourth-quarter 2025 results showing sales of US$3,347 million and net income of US$200 million, alongside full-year 2025 sales of US$13.16 billion and diluted earnings per share from continuing operations of US$3.30. Management also projected comparable diluted earnings per share growth of above 10% for 2026 and affirmed a quarterly dividend of US$0.20 per share, underscoring confidence in Ball’s post-divestiture, aluminum-packaging-focused...

Thermon Group Holdings (THR) is back on investors’ radar after third quarter results showed higher sales, steady profitability, and stronger year to date figures, along with commentary pointing to opportunities in electrification and infrastructure spending. See our latest analysis for Thermon Group Holdings. Those third quarter results, together with plans for acquisitions funded by US$141 million of available liquidity and a completed share buyback, sit alongside a strong recent run, with a...

Plug Power (PLUG) is in the spotlight after a new securities class action lawsuit, leadership changes, and an upcoming shareholder vote converge with its Project Quantum Leap cost saving and profitability plan. See our latest analysis for Plug Power. The recent class action filings, leadership change and upcoming charter vote come after a tough stretch for the share price, with a 90 day share price return of 25.27% decline but a 1 year total shareholder return of 25.93% gain. This suggests...

Under Armour, Inc. reported past third-quarter 2025 results showing sales of US$1,327.76 million versus US$1,401.04 million a year earlier, and a net loss of US$430.83 million compared with prior net income of US$1.23 million, while also guiding to a full-year revenue decline and deeper operating loss amid tariff and demand pressures. Despite weaker revenues and elevated losses, management raised its full-year profit outlook and highlighted early benefits from its operating model overhaul,...

Parker-Hannifin recently reported second-quarter fiscal 2026 results showing higher sales of US$5,174 million compared to a year earlier, alongside slightly lower net income of US$845 million, and simultaneously completed a long-running share repurchase program totaling 30,913,829 shares for about US$6.43 billion. The company also raised its full-year fiscal 2026 outlook for sales growth, segment operating margins, and both reported and adjusted EPS, signaling increased management confidence...

As February 2026 begins, the U.S. stock market has seen a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as government shutdowns and changes in Federal Reserve leadership. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential, adaptability to market shifts, and financial...

As the U.S. stock market kicks off February with significant gains, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing a record high, investors are keenly observing opportunities amid this bullish sentiment. In such an environment, identifying stocks that may be trading below their fair value can present potential investment opportunities, particularly when considering companies like Autodesk and others that might offer strong fundamentals at attractive...

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.

As February 2026 begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this dynamic market environment, dividend stocks can offer investors a blend of income and potential growth, making them an attractive consideration amidst ongoing economic developments.

Moody’s recently came under pressure after weaker earnings guidance from industry peer S&P Global raised concerns about conditions facing credit rating and financial data providers. The episode highlights how sentiment toward one major ratings and data firm can quickly influence expectations for others ahead of their own results. We’ll now examine how these sector-wide worries about earnings sustainability could affect Moody’s investment narrative built around private credit and...

In early February 2026, Bruker, through its Chemspeed Technologies and SciY divisions, introduced an open Self-Driving Lab platform and launched the iNTApharma nanoscale bioparticle characterization system at SLAS2026, while also declaring a quarterly cash dividend of US$3.9844 per share on its 6.375% Mandatory Convertible Preferred Stock. By combining autonomous, AI-orchestrated lab workflows with label-free, native-state nanoparticle analysis, Bruker is targeting bottlenecks in advanced...

In February 2026, Humacyte, Inc. reported that the U.S. Department of Defense’s Fiscal Year 2026 Appropriations Act includes dedicated funding to evaluate and incorporate biologic vascular repair technologies, directly aligning with its FDA-approved human-derived bioengineered blood vessel Symvess for traumatic extremity vascular injuries in service members. This federal support highlights growing institutional recognition of bioengineered human vessels as an off-the-shelf option when...

Keysight Technologies (NYSE: KEYS) has launched its SOS Enterprise platform, focused on AI readiness and compliance in engineering data management. The platform is designed to organize engineering data, automate compliance tasks, and support secure AI integration for sectors such as aerospace and automotive. Keysight Technologies, trading at $235.0, is drawing attention from investors as it connects its test and measurement expertise with data centric software such as SOS Enterprise. The...

Globus Medical stock in focus after recent price moves Globus Medical (GMED) is back on investor radars after recent trading left the share price around $88.72, with returns mixed over the past month and the past 3 months. See our latest analysis for Globus Medical. The recent 1 day share price return of 1.29% sits against a softer 30 day share price return of 6.09% and a year to date share price return of 1.63%. The 1 year total shareholder return of 5.27% and 3 year total shareholder return...

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...

Why this earnings report matters for IES Holdings (IESC) IES Holdings (IESC) just posted first quarter results that put fresh numbers around the company’s current momentum, with higher sales, higher net income and higher earnings per share compared with the same period a year ago. See our latest analysis for IES Holdings. The strong first quarter update comes on top of an intense share price run, with an 18.82% 7-day share price return, 28.40% 90-day share price return and very large...

Citizens Financial Group recently presented at the KBW 2026 Winter Financial Services Conference in Boca Raton, outlining its latest banking initiatives and market priorities. The bank’s push into new geographies, greater use of AI, and expanded private banking and capital markets capabilities marks a meaningful shift in how it aims to grow and manage risk. We’ll now explore how Citizens’ nationwide expansion and AI-driven efficiency push could reshape its existing investment narrative for...